Adalimumab is effective in patients with preradiographic axial spondyloarthritis (PRSPA): Results of a 12-week, randomised controlled trial with a 40-week open-label extension (OLE)

被引:0
|
作者
Haibel, H. [1 ]
Rudwaleit, M. [1 ]
Amtenbrink, A. [1 ]
Heldmann, F. [2 ]
Listing, J. [3 ]
Wong, R. [4 ]
Kupper, H. [5 ]
Braun, J. [2 ]
Sieper, J. [1 ]
机构
[1] Charite Univ Med Berlin, D-13353 Berlin, Germany
[2] Ruhrgebeit, Herne, Germany
[3] German Rheumatism Res Ctr, Berlin, Germany
[4] Abbott, Parsippany, NJ USA
[5] Abbott GmbH & Co KG, Ludwigshafen, Germany
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:II80 / II80
页数:1
相关论文
共 50 条
  • [31] Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: A 12-week randomized controlled clinical trial with a 52-week open-label extension
    Reiff, A
    Lovell, DJ
    van Adelsberg, J
    Kiss, MHB
    Goodman, S
    Zavaler, MF
    Chen, PY
    Bolognese, JA
    Cavanaugh, PF
    Reicin, AS
    Giannini, EH
    [J]. JOURNAL OF RHEUMATOLOGY, 2006, 33 (05) : 985 - 995
  • [32] Continuous efficacy of etanercept in severe and advanced ankylosing spondylitis: results from a 12-week open-label extension of the SPINE study
    Dougados, Maxime
    Braun, Jurgen
    Szanto, Sandor
    Combe, Bernard
    Geher, Pal
    Leblanc, Veronique
    Logeart, Isabelle
    [J]. RHEUMATOLOGY, 2012, 51 (09) : 1687 - 1696
  • [33] A 12-week randomized open-label study of dermatological precautions with lamotrigine in bipolar disorder patients
    Graham, JA
    Ketter, TA
    Roberts, J
    DeVeaugh-Geiss, AM
    Thompson, TR
    [J]. BIPOLAR DISORDERS, 2005, 7 : 62 - 62
  • [34] A 12-week randomized open-label study of dermatological precautions with lamotrigine in bipolar disorder patients
    Ketter, TA
    Graham, J
    Thompson, T
    Nanry, K
    [J]. EPILEPSIA, 2005, 46 : 176 - 176
  • [35] Long term effects of rivastigmine in patients with traumatic brain injury with cognitive deficits: Results of a 26-week open-label extension to a 12-week double-blind study
    Gunay, Ibrahim
    Koumaras, Barbara
    Silver, Jonathan
    [J]. ANNALS OF NEUROLOGY, 2006, 60 : S62 - S62
  • [36] Clinical evolution of substance use disorder patients during treatment with quetiapine: a 12-week, open-label, naturalistic trial
    Rizkallah, Elie
    Stip, Emmanuel
    Zhornitsky, Simon
    Pampoulova, Tania
    Gendron, Alain
    Rompre, Pierre-Paul
    Chiasson, Jean-Pierre
    Potvin, Stephane
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (18) : 2947 - 2951
  • [37] EFFICACY AND SAFETY OF ADALIMUMAB IN PATIENTS WITH NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM THE 28-WEEK OPEN-LABEL PERIOD OF THE ABILITY-3 STUDY
    Landewe, R.
    Sieper, J.
    Inman, R.
    Pangan, A. L.
    Wang, X.
    Anderson, J. K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 353 - 354
  • [38] Effect of aripiprazole as an adjunct to atypical antipsychotics on weight and metabolic profile: a 12-week open-label trial
    Gupta, Bhanu
    Chee, Kok-Seng
    Neo, Li-Qi
    Tang, Charmaine
    Hariram, Jayaraman
    Tan, Geoffrey Chern-Yee
    Verma, Swapna
    Basu, Sutapa
    Appan, Deva-Priya
    Ting, Chan-Chun
    Abdin, Edimansyah
    Lee, Jimmy
    [J]. THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2021, 11
  • [39] Ziprasidone versus olanzapine, risperidone or quetiapine in patients with chronic schizophrenia: A 12-week open-label, multicentre clinical trial
    Lublin, Henrik
    Haug, Hans-Joachim
    Koponen, Hannu
    Sigmundsson, Thordur
    Kolb, Stefan A.
    [J]. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, 2009, 10 (04): : 710 - 718
  • [40] Modification of structural lesions on MRI of the sacroiliac joints by etanercept in the EMBARK trial: a 12-week randomised placebo-controlled trial in patients with non-radiographic axial spondyloarthritis
    Maksymowych, Walter P.
    Wichuk, Stephanie
    Dougados, Maxime
    Jones, Heather E.
    Pedersen, Ron
    Szumski, Annette
    Marshall, Lisa
    Bukowski, Jack F.
    Lambert, Robert G.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (01) : 78 - 84